AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03638869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REL-1017
Description: The investigational product, REL-1017 is prepared as a solution with Ocean Spray® Diet Cranberry Juice on site to obtain a final volume of 100 mL for dosing. The study drug will be administered as a solution of 25 mg, 50 or 75 mg REL-1017 for 10 days, based on randomization prepared in Ocean Spray® Diet Cranberry Juice with a final volume of 100 mL.
Study NCT03638869 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02818036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone
Study NCT02818036 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02491034 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Depression Education Intervention
Description: Depression Education Intervention (DEI) designed to increase disease literacy, and dispel myths about depression and its treatment among Hispanic patients thus reducing stigma and increasing treatment engagement.
Study NCT00869050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine 1500 mg/m2/day (PO divided BID) with a maximum daily dose of 2500mg Two week treatment regimen followed by two weeks off treatment, repeated for 12 cycles~After patients have completed 12 cycles with no signs of progression of disease, radiologic evaluation (CT or MRI) will be done after three cycles. This will result in two 28 day cycles and one 35 day cycle.
Study NCT00869050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Temozolomide 150-200 mg/m2/day (PO divided BID).~Two week treatment regimen followed by two weeks off treatment, repeated for 12 cycles~After patients have completed 12 cycles with no signs of progression of disease, radiologic evaluation (CT or MRI) will be done after three cycles. This will result in two 28 day cycles and one 35 day cycle.
Study NCT03849690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-906
Description: TAK-906 capsules.
Study NCT03849690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Description: Esomeprazole capsules.
Study NCT03251859 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg
Description: Ticagrelor 90 mg twice daily
Study NCT03251859 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor 90 mg
Description: Ticagrelor 90 mg twice daily
Study NCT03251859 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg
Description: Ticagrelor 60 mg daily
Study NCT05202665 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ICON DMG Resin Infiltration (micro-invasive approach)
Description: A plastic wedge located below the contact point to apart from the surface from adjacent tooth. A 15% HCl etching gel (Icon, DMG, Hamburg, Germany) was applied by syringe below the contact point for 120 s. After, the gel was washed off with air-water-spray for 30 s. The lesion was desiccated by air-blowing for 10 s, application of ethanol for 30 s and air-blowing again for 30 s. A resin infiltrant (Icon, DMG, Hamburg, Germany) was applied with another plastic holder during 3 min. Following the penetration, excess of material was removed by air blowing and flossing. The resin was light-cured for 40 s total from the buccal, occlusal, and lingual/palatal aspects. It was needed to reapplicate the resin infiltration for once because of infiltrating remaining porosities during 1 minute. Excess material removing process was again repeated and light cured for 40 s.
Study NCT05202665 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ClinproTM White Varnish, 3M ESPE Fluoride Varnish (non-invasive approach)
Description: Tooth surfaces were cleaned thoroughly and isolated with cotton rolls. According to the manufacturer's instructions, the unit dose packages were opened, and the contents were dispensed onto the application guide and mixed to avoid the separation of sodium fluoride components. A thin coat of varnish (ClinproTM White Varnish, 3M ESPE, USA) with 22600 ppm fluoride was applied to the tooth interface with a brush tip applicator and waited for 5 minutes. Aproximal areas were coated with dental floss. The patient was instructed not to rinse or apply suction immediately after application. Patients were advised to avoid eating hard and sticky foods or drinking hot beverages for the next 2 hours, to consume a soft diet immediately after 30 minutes and to avoid brushing and flossing for the rest of the day.
Study NCT03297489 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diagnostic Microscopy
Description: Undergo observation via intravital microscopy
Study NCT03297489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorescein Sodium Injection
Description: Given IV
Study NCT03297489 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT04253990 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Precut EMR
Description: For treating of 10\~20mm colon polyp, patient will be randomly divided into two groups, a Precut-EMR group and a EMR group.~In Precut-EMR, endoscopist submucosally inject with saline around a polyp. Subsequently, circumferential incision/precutting was made with the tip of the snare around 2 mm outside the tumor. After that, the snare was positioned in the cut groove and tightend, and the tumor was resected using electrical current.
Study NCT04253990 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional MER
Description: EMR had been widely used technique. Endoscopist submucosally inject with saline around a polyp. After that, snare is positioned around a polyp, and polyp was resected using electrical current.
Study NCT02256267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2835219
Description: Administered orally
Study NCT02256267 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampin
Description: Administered orally
Study NCT02109523 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI
Description: Five weekly motivational and volitional session sessions and each last about 50 minutes. Five registered psychologists will moderated the session. All MI technique and planing intervention will be used.
Study NCT02109523 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: volitional intervention
Description: Five weekly motivational and volitional session sessions and each last about 50 minutes. Five registered psychologists will moderated the session. All MI technique and planing intervention will be used.
Study NCT02109523 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Routine discharge counseling
Study NCT03359057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ethinyl estradiol + levonorgestrel + folic acid
Description: One coated tablet of ethinyl estradiol + levonorgestrel + folic acid, 0.02 mg + 0.10 mg + 0.4 mg for 21 days in 3 cycles (12 weeks).
Study NCT03359057 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Folic Acid
Description: One coated tablet of folic acid 0.4 mg for 7 days in 3 cycles (12 weeks).
Study NCT01282190 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational interview
Description: Motivational interview
Study NCT04576390 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron 4 mg
Description: Antiemetic drug
Study NCT04576390 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Palonosetron 75 mcg
Description: Antiemetic drug
Study NCT02276690 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: hepcidin
Description: In order to assess iron deficiency by innovative method (dosage of Hepcidin), an additional collection of blood will be done at day 0 (and weekly until Intensive Care Unit discharge) and at Day 15 after Intensive Care Unit discharge.~Treatement of Iron deficiency anaemia and anaemia of chronic disease using intravenous iron (± erythropoietin) will be encouraged (or not) according to hepcidin levels
Study NCT02276690 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ferritin and transferrin saturation
Description: In order to assess iron deficiency by using usual biomarkers (ferritin and transferrin saturation), collection of blood will be done at day 0 (and weekly until Intensive Care Unit discharge) and at Day 15 after Intensive Care Unit discharge.~Treatement of Iron deficiency anaemia and anaemia of chronic disease using intravenous iron (± erythropoietin) will be encouraged (or not) according to ferritin levels.
Study NCT00935701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupressure and Acupuncture
Description: Acupressure involves the stimulation of specific acupoints by firm pressure, while acupuncture involves the insertion of very fine needles (the size of a strand of hair). The needles may be quickly inserted and removed or left in up to 5 minutes at a time.
Study NCT04294316 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Sonovue
Description: Twice dose of 2.4ml of Sulphur hexafluoride microbubbles contrast Sonovue administration to evaluate brain microcirculation
Study NCT01239888 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: 20 IU of intranasal oxytocin twice per day for 8 weeks, and a placebo (oral) for the 8 week trial
Study NCT01239888 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin and Tibolone
Description: 20 IU of intranasal oxytocin twice per day for 8 weeks, and 2.5mg oral tibolone for the 8 week trial
Study NCT01239888 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 20 IU of intranasal placebo twice per day for 8 weeks, and a placebo (oral) for the 8 week trial
Study NCT01892761 — intervention group
Intervention type: DRUG
Intervention: Renal transplant recipients were allocated to TCL/MMF or to CyA/MMF groups
Study NCT03003078 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: OncoSil™
Description: The implantation of OncoSil™
Study NCT00266838 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Maxidex; Lacrystat
Description: 6 times daily, for 20 weeks.
Study NCT00266838 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Maxidex; Lacrystat
Description: 6 times daily, for 20 weeks.
Study NCT01269424 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: O6-benzylguanine
Study NCT01269424 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: temozolomide
Study NCT05172453 — intervention group
Intervention type: OTHER
Intervention: comprehensive management algorithm for preventing mother-to-child transmission of HBV
Description: To standardize the clinical management of preventing MTCT of HBV and reduce incidences of MTCT, the Chinese Foundation for Hepatitis Prevention and Control (CFHPC) organized experts to compile the Management algorithm for prevention of mother-to-child transmission of hepatitis B virus based on the latest research progress and recently published guidelines, which includes 10 steps of pregnancy management and postpartum follow-up, among which screening, antiviral treatment, and infant immunization are its core contents.
Study NCT00894218 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroplasty
Description: Hip or knee arthroplasty
Study NCT01269424 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: laboratory biomarker analysis
Study NCT03037099 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced GI Concept Education
Study NCT03504813 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activities program
Description: To implement this line, the protocol of the VIVIFRAIL Project will be used as a reference. That protocol has different physical exercises, divided into itineraries, in order to adapt it to a person's capability. Several sessions of this research line will employ the use of videogames so that the elderly can explore new forms of physical activity and thus establish contact and expertise with new technologies. It is estimated that two sessions per week over two months are needed for each person to continue doing physical activity independently and with autonomy.
Study NCT01269424 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: autologous hematopoietic stem cell transplantation
Study NCT03504813 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Relaxation training
Description: Will take place with those participants who are included in the research lines of insomnia and risk of falls. It is estimated that two sessions per week for one month are needed.
Study NCT03504813 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training of the pelvic floor
Description: the intervention will apply to participants enrolled in the research line dealing with urinary incontinence during the six months of intervention, with a frequency of two sessions per week
Study NCT03504813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling about occupational performance
Description: After the physical activity and relaxation programs, the counselling will start. With each participant, routines and daily activities will be planned that will be adequate according to different recommendations about urinary incontinence, insomnia and risk of falls. Different performance guidelines will be established in order to establish a good balance between activities. The guidelines can include the recommendations about adjustments to the environment. It is estimated that three sessions per week for two months are needed to incorporate advice and routines into the daily lives of participants.
Study NCT01269424 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: in vitro-treated peripheral blood stem cell transplantation
Study NCT01269424 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiation therapy
Study NCT01361464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tipifarnib
Description: Given PO
Study NCT01361464 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01537029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: Dosed by the patient's treating physician according to local standard of care.
Study NCT01537029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: dosage form: IV, Dosage, frequency, and duration: According to local standard of care
Study NCT04837157 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exoskeleton rehabilitation
Description: The participants will perform physical therapy with the ATLSA2030 device, for 90 minutes per session.
Study NCT02511366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ileal infusion of casein
Description: Intraileal infusion of casein
Study NCT02511366 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Ileal infusion of tap water
Description: Intraileal infusion of tap water
Study NCT01344161 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: dosage form:lactose dosage: 25 micrograms frequency: every day duration: 12weeks
Study NCT00586833 — intervention group
Intervention type: PROCEDURE
Intervention: O2 consumption max bike test
Description: Single visit exercise study
Study NCT02220023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INOmax Inhalation
Study NCT01544452 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: MR colonography and MR of the liver
Description: Altered planned surgical procedure if MR colonoscopy reveals synchronous cancer or larger polyps
Study NCT01544452 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Standard diagnostic evaluation
Description: Altered planned surgical procedure if MR colonoscopy reveals synchronous cancer or larger polyps
Study NCT02249494 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: telehealth
Description: Use the call service offered by the Center for Telehealth Rio Grande do Sul to answer clinic questions with qualified staff and in real time. All physicians who work in Primary Health Care in Brazil can call when they have questions about diagnosis and management of their patients.
Study NCT02249494 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: telehealth
Description: Use the call service offered by the Center for Telehealth Rio Grande do Sul to answer clinic questions with qualified staff and in real time. All physicians who work in Primary Health Care in Brazil can call when they have questions about diagnosis and management of their patients.
Study NCT02249494 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nutritional counseling
Description: Performing routine nutritional counseling in their clinical practice
Study NCT02018549 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inhalation through Chiesi NEXThaler DPI
Description: Inhalatory manoeuvre through Chiesi NEXThaler DPI repeated at least twice in order to have two evaluable data set
Study NCT03032198 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Imagio OA/US
Description: Diagnostic opto-acoustic gray-scale ultrasound
Study NCT00746759 — intervention group
Intervention type: DEVICE
Intervention: Biomarker (not used as an intervention)
Description: This study is an observational study. There is no intervention.
Study NCT01885559 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lisinopril
Description: Lisinopril titrated to 5mg, 10mg, 20mg, 40mg as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.
Study NCT01885559 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Lisinopril
Description: Lisinopril titrated to 5mg, 10mg, 20mg, 40mg as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.
Study NCT01885559 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Telmisartan
Description: Telmisartan titrated to 40mg and 80mg, as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.
Study NCT01885559 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo titrated to 40mg and 80mg, as tolerated by participants, to achieve standard blood pressure control of 110-130/80 mm Hg.
Study NCT02249494 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: nutritional counseling
Description: Performing routine nutritional counseling in their clinical practice
Study NCT02249494 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: smartphone (mobile app)
Description: Mobile app, designed to provide nutritional recommendations for hypertensive patients, will be use. The recommendations will be based on the DASH diet guidelines appropriate to the patient profile: consumption of whole grains, fruits, vegetables, milk or low fat dairy products, lean meats, poultry and fish, nuts, seeds and legumes, amount of fats, oils and sweets, as well as guidelines for salt intake and alcohol.
Study NCT02046304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Starting dose: 400 mg/m2 by vein on days 1, 8, 22, 29, 43, and 50.
Study NCT02046304 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Radiation therapy dose of 50 Gy in 25 fractions at 2.0 Gy per fraction. Radiotherapy given once daily (Monday through Friday) for 5 weeks.
Study NCT02318810 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 0.3 mg/kg
Description: Patients receive rocuronium 0.3 mg/kg
Study NCT02318810 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 0.6 mg/kg
Description: Patients receive rocuronium 0.6 mg/kg
Study NCT02318810 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 0.9 mg/kg
Description: Patients receive rocuronium 0.9 mg/kg
Study NCT02318810 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients receive saline
Study NCT03102892 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaling root planing
Description: Treatment by scaling and root planing alone.
Study NCT03102892 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling root planing
Description: Treatment by scaling and root planing alone.
Study NCT03102892 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy
Description: Treatment with methylene blue dye and red laser
Study NCT03650166 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MyBP
Description: This program includes online video high BP education and longitudinal, personalized assistance of home BP self-monitoring.
Study NCT03650166 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Personal BP monitor
Description: Battery-powered BP monitor for personal use
Study NCT03650166 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personal BP monitor
Description: Battery-powered BP monitor for personal use
Study NCT03247595 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Magnesium Citrate Capsules
Description: 36 magnesium citrate gelatin capsules
Study NCT03247595 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene Glycol 3350
Description: 4 liters of Polyethylene Glycol for colonoscopy preparation
Study NCT03247595 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dulcolax Tablets
Description: 4 Dulcolox Tablets